Literature DB >> 35040152

Regulatory strategies limiting endosomal Toll-like receptor activation in B cells.

Mridu Acharya1,2, Shaun W Jackson1,2.   

Abstract

The recognition of pathogen-associated nucleic acid (NA) promotes effective immunity against invading pathogens. However, endosomal Toll-like receptor (TLR) activation by self-NA also underlies the pathogenesis of systemic autoimmune diseases, such as systemic lupus erythematosus (SLE). For this reason, the activation thresholds of NA-sensing TLRs must be tightly regulated to balance protective and pathogenic immune responses. In this study, we will provide an overview of the evolutionary mechanisms designed to limit the aberrant activation of endosomal TLRs by self-ligands, focusing on four broad strategies. These include the following: 1) the production of nucleases able to degrade self-DNA and RNA; 2) the cell-specific regulation of endosomal TLR expression; 3) the spatial and temporal control of TLR positioning at a sub-cellular level; and 4) the modulation of downstream TLR signaling cascades. Given the critical role of B cells in lupus pathogenesis, where possible, we will describe evidence for B cell-specific induction of these regulatory mechanisms. We will also highlight our own work showing how modulation of B cell endolysosomal flux tunes NA-sensing TLR activation signals. In the face of inevitable generation of self-NA during normal cellular turnover, these parallel mechanisms are vital to protect against pathogenic inflammation.
© 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  B cells; Toll-like receptors; endolysosomal trafficking; non-canonical autophagy; systemic lupus erythematosus

Mesh:

Substances:

Year:  2022        PMID: 35040152      PMCID: PMC8986562          DOI: 10.1111/imr.13065

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   10.983


  112 in total

1.  Endocytic pathways regulate Toll-like receptor 4 signaling and link innate and adaptive immunity.

Authors:  Harald Husebye; Øyvind Halaas; Harald Stenmark; Gro Tunheim; Øystein Sandanger; Bjarne Bogen; Andreas Brech; Eicke Latz; Terje Espevik
Journal:  EMBO J       Date:  2006-02-09       Impact factor: 11.598

Review 2.  Biological Functions of Autophagy Genes: A Disease Perspective.

Authors:  Beth Levine; Guido Kroemer
Journal:  Cell       Date:  2019-01-10       Impact factor: 41.582

3.  Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF.

Authors:  V A Fadok; D L Bratton; A Konowal; P W Freed; J Y Westcott; P M Henson
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

4.  Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classification.

Authors:  Melissa E Munroe; Rufei Lu; Yan D Zhao; Dustin A Fife; Julie M Robertson; Joel M Guthridge; Timothy B Niewold; George C Tsokos; Michael P Keith; John B Harley; Judith A James
Journal:  Ann Rheum Dis       Date:  2016-01-25       Impact factor: 19.103

5.  A single nucleotide polymorphism in the NCF1 gene leading to reduced oxidative burst is associated with systemic lupus erythematosus.

Authors:  Lina M Olsson; Åsa C Johansson; Birgitta Gullstrand; Andreas Jönsen; Saedis Saevarsdottir; Lars Rönnblom; Dag Leonard; Jonas Wetterö; Christopher Sjöwall; Elisabet Svenungsson; Iva Gunnarsson; Anders A Bengtsson; Rikard Holmdahl
Journal:  Ann Rheum Dis       Date:  2017-06-12       Impact factor: 19.103

Review 6.  Altered B cell signalling in autoimmunity.

Authors:  David J Rawlings; Genita Metzler; Michelle Wray-Dutra; Shaun W Jackson
Journal:  Nat Rev Immunol       Date:  2017-04-10       Impact factor: 53.106

7.  Selective control of type I IFN induction by the Rac activator DOCK2 during TLR-mediated plasmacytoid dendritic cell activation.

Authors:  Kazuhito Gotoh; Yoshihiko Tanaka; Akihiko Nishikimi; Risa Nakamura; Hisakata Yamada; Naoyoshi Maeda; Takahiro Ishikawa; Katsuaki Hoshino; Takehito Uruno; Qinhong Cao; Sadayuki Higashi; Yasushi Kawaguchi; Munechika Enjoji; Ryoichi Takayanagi; Tsuneyasu Kaisho; Yasunobu Yoshikai; Yoshinori Fukui
Journal:  J Exp Med       Date:  2010-03-15       Impact factor: 14.307

8.  Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice.

Authors:  Marie-Laure Santiago-Raber; Isabelle Dunand-Sauthier; Tianfu Wu; Quan-Zhen Li; Satoshi Uematsu; Shizuo Akira; Walter Reith; Chandra Mohan; Brian L Kotzin; Shozo Izui
Journal:  J Autoimmun       Date:  2009-11-26       Impact factor: 7.094

9.  B Cell αv Integrins Regulate TLR-Driven Autoimmunity.

Authors:  Mridu Acharya; Fiona Raso; Sara Sagadiev; Emily Gilbertson; Lauren Kadavy; Quan Z Li; Mei Yan; Lynda M Stuart; Jessica A Hamerman; Adam Lacy-Hulbert
Journal:  J Immunol       Date:  2020-08-28       Impact factor: 5.422

10.  DNASE1L3 mutations in hypocomplementemic urticarial vasculitis syndrome.

Authors:  Z Birsin Ozçakar; Joseph Foster; Oscar Diaz-Horta; Ozgur Kasapcopur; Yao-Shan Fan; Fatoş Yalçınkaya; Mustafa Tekin
Journal:  Arthritis Rheum       Date:  2013-08
View more
  1 in total

1.  Many Achilles' heels of B and T cell tolerance.

Authors:  Roberta Pelanda; Julie Zikherman
Journal:  Immunol Rev       Date:  2022-03-18       Impact factor: 12.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.